---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-339389"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2021-11-24T23:59:59+00:00"
generated_at: "2026-06-28T05:37:20.311456+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Teva appoints Amir Weiss as Chief Accounting Officer, replacing Andrew Weil

## Summary
- Andrew Weil steps down as Chief Accounting Officer effective November 24, 2021.
- Amir Weiss promoted from VP Finance and Corporate Controller to SVP and Chief Accounting Officer, effective same date.
- Weiss's base salary increased to 840,000 NIS; eligible for 50% target annual cash incentive and equity awards.
- Weiss joined Teva in 2012 and holds an MA in law, MBA, and CPA.

## SEC filing metadata
- accession: 0001193125-21-339389
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2021-11-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/0001193125-21-339389-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/d222550d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-339389
- JSON: https://secwatch.observer/filing/0001193125-21-339389.json
- Plain text: https://secwatch.observer/filing/0001193125-21-339389.txt

## Key facts
- Executive change
  Amir Weiss was appointed as Senior Vice President and Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD.
  - Action: promoted
  - Role: Senior Vice President and Chief Accounting Officer
  source text: Amir Weiss, currently Vice President of Finance and Corporate Controller, was promoted to Senior Vice President and Chief Accounting Officer, effective November 24, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/0001193125-21-339389-index.htm
- Executive change
  Andrew Weil departed as Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD.
  - Action: stepped down
  - Role: Chief Accounting Officer
  source text: Andrew Weil, Teva’s Chief Accounting Officer, will step down from his role as Chief Accounting Officer, effective November 24, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/0001193125-21-339389-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.